StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.73−0.05 (-2.81%)

Close on Nov 18, 2026Market cap $52.74MP/E –Yield –

XBiotech gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

XBiotech's gross profit for the twelve months ending Dec 31, 2023 was $0, down 100.0% year over year. For fiscal 2023 it was $0, down 100.0% from the year before. The highest annual figure on record is $12.57M in fiscal 2021.

Annual gross profit

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$3.36M-73.3%
FY2021Dec 31, 2021$12.57M+33.1%
FY2020Dec 31, 2020$9.45M–
FY2019Dec 31, 2019$0–
FY2018Dec 31, 2018$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$284.00K-91.8%
Q3 FY2022Sep 30, 2022$1.47M-57.0%
Q2 FY2022Jun 30, 2022$1.32M-58.2%
Q1 FY2022Mar 31, 2022$287.00K-88.7%
Q4 FY2021Dec 31, 2021$3.45M+14.3%
Q3 FY2021Sep 30, 2021$3.41M+203.6%
Q2 FY2021Jun 30, 2021$3.17M+37.8%
Q1 FY2021Mar 31, 2021$2.55M-15.3%
Q4 FY2020Dec 31, 2020$3.02M–
Q3 FY2020Sep 30, 2020$1.12M–
Q2 FY2020Jun 30, 2020$2.30M–
Q1 FY2020Mar 31, 2020$3.01M–
Q4 FY2019Dec 31, 2019$0–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0–

More XBiotech figures

See a number that looks wrong?